Top Insider Trades: SNTA EPZM UBNT MVC

By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading.

NEW YORK ( TheStreet) -- It is a victory for common sense. Tracking the trading behavior of company executives, directors and large shareholders in the stocks of firms they're registered in as "insiders" has proven to be profitable, according to both academic studies and (more importantly) the experience of professional investors.

Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Thursday, June 6, 2013 as ranked by dollar value. Please note, however, that these are only factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these regular Top Insider Trades columns as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to contact us with any questions on our proprietary insider data, and how it is best analyzed.
Summit Midstream (SMLP) Summit Midstream DIR,BO 1,553,849 48,992,860
Synta (SNTA) Kovner B DIR,BO 2,000,000 9,270,354
Spectrum Brands (SPB) Harbinger BO 63,001 3,882,662
New Peoples (NWPP) Keene H DIR,BO 700,000 1,050,000
Epizyme (EPZM) Celgene Euro BO 66,666 999,990
MVC Cap (MVC) Goldstein P DIR 26,370 334,590
NY Com (NYCB) Rosenfeld R DIR 20,000 261,370
Epizyme (EPZM) Astellas Venture BO 15,333 229,995
Biologix (BLGX) Keller W DIR 200,000 200,000
Apollo Inv (AINV) Zelter J CEO,DIR 20,000 159,200
Source: Insider Insights
Ubiquiti (UBNT) Summit BO 6,000,000 96,000,000
Exacttarget (ET) Greenspring BO 2,314,342 78,013,920
Lululemon (LULU) Wilson D DIR,BO 392,455 32,130,882
Monro (MNRO) Gross R DIR 133,737 6,347,083
Bristol Myers (BMY) Andreotti L CEO,DIR 100,000 4,774,000
Jarden (JAH) Franklin M CB,DIR 100,002 4,591,092
YELP (YELP) Wilson L GC,SEC 140,250 3,878,568
Jarden (JAH) Ashken I VCB,CFO,DIR 60,000 2,754,000
Tutor Perini (TPC) Tutor R CB,CEO,BO 110,930 1,957,892
Lpl (LPLA) Stiefler J DIR 46,942 1,745,304
Source: Insider Insights

Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, EVP=Executive Vice President, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.
Jonathan Moreland is the founder of, which produces a weekly newsletter and offers professional screening and alerting tools to analyze a proprietary, real-time insider data feed. He is also the principal of Insider Asset Management, a registered investment advisor in New York. Mr. Moreland has been analyzing insider data professionally for two decades and has been a contributor to since 2001. A fundamental analyst with an MBA in finance, Mr. Moreland long ago identified insider data as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

If you liked this article you might like

Fly Watch: Several Names That May Move Following ASCO Meeting

Synta Pharmaceuticals (SNTA) Stock Rises Today After Announcing Upcoming Presentations

Synta Pharmaceuticals (SNTA) Stock Hits 52-Week Low After Pricing Public Offering

5 Stocks Under $10 Set to Soar: Breakout Stocks

Interesting SNTA Call Options For March 20th